ACNE SOLUTIONS CLARIFYING- salicylic acid liquid 
CLINIQUE LABORATORIES LLC

----------

ACNE SOLUTIONS CLARIFYING LOTION

Drug Facts

Active ingredient

Salicylic acid 1.5%

Purpose

Acne treatment

Uses

Warnings

For external use only.

When using this product using other topical acne drugs at the same time or right after use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

CAUTION: Flammable until dry. Do not use near heat or flame.

Inactive ingredients

water • alcohol denat. • nylon-12 • butylene glycol • hamamelis virginiana (witch hazel) • laminaria saccharina extract • caffeine • sucrose • glycerin • acetyl glucosamine • sorbitol • sea whip extract • barium sulfate • 10-hydroxydecanoic acid • silica • disodium edta • benzalkonium chloride [iln32340]

DIST. N.Y., N.Y. 10022
NEW YORK • LONDON W1K 3BQ • PARIS

PRINCIPAL DISPLAY PANEL - 200 ml Bottle Carton

CLINIQUE

acne solutions

clarifying lotion

STEP 2
SALICYLIC ACID ACNE MEDICATION

6.7 FL.OZ./200 ml e

PRINCIPAL DISPLAY PANEL - 200 ml Bottle Carton
ACNE SOLUTIONS CLARIFYING 
salicylic acid liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49527-723
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID15 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
NYLON-12 (UNII: 446U8J075B)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK (UNII: T7S323PKJS)  
SACCHARINA LATISSIMA (UNII: 68CMP2MB55)  
CAFFEINE (UNII: 3G6A5W338E)  
SUCROSE (UNII: C151H8M554)  
GLYCERIN (UNII: PDC6A3C0OX)  
N-ACETYLGLUCOSAMINE (UNII: V956696549)  
SORBITOL (UNII: 506T60A25R)  
PSEUDOPTEROGORGIA ELISABETHAE (UNII: UDY3H1OUX5)  
BARIUM SULFATE (UNII: 25BB7EKE2E)  
10-HYDROXYDECANOIC ACID (UNII: NP03XO416B)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:49527-723-011 in 1 CARTON09/01/2006
1200 mL in 1 BOTTLE; Type 0: Not a Combination Product
2NDC:49527-723-021 in 1 CARTON03/02/2022
260 mL in 1 BOTTLE; Type 0: Not a Combination Product
3NDC:49527-723-03100 mL in 1 BOTTLE; Type 0: Not a Combination Product10/20/2023
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00609/01/2006
Labeler - CLINIQUE LABORATORIES LLC (044475127)
Registrant - Estee Lauder Companies Inc. (790802086)
Establishment
NameAddressID/FEIBusiness Operations
The Estee Lauder Inc802599436manufacture(49527-723) , pack(49527-723) , label(49527-723)
Establishment
NameAddressID/FEIBusiness Operations
NORTHTEC KEYSTONE949264774label(49527-723) , pack(49527-723)
Establishment
NameAddressID/FEIBusiness Operations
PALC078364654label(49527-723) , pack(49527-723)

Revised: 12/2023
Document Id: 0d0e0de0-5c59-1cf0-e063-6394a90a222d
Set id: dc1b2e2e-0e13-4029-bdac-44adb70492fd
Version: 10
Effective Time: 20231221
 
CLINIQUE LABORATORIES LLC